The DOI matches its Crossref record; 2,264 of the 2,264 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 2,001–2,200 of 2,264
Bruheim, S., Krobert, K. A., Andressen, K. W., et al. (2003) · Receptors and Channels · doi:10.1080/10606820308245 · Cited by 27
Marchetti, E., Jacquet, M., Escoffier, G., Migliorati, M., Dumuis, A., Bockaert, J., & Roman, F. S. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.020 · Cited by 27
Self-citationSanger, G. J., & Wardle, K. A. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03879.x · Cited by 27
Self-citationImprovement of ketamine-induced social withdrawal in rats
Hołuj, M., Popik, P., & Nikiforuk, A. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000132 · Cited by 27
Akiyoshi, T., Zhang, Q., Inoue, F., Aramaki, O., Hatano, M., Shimazu, M., Kitajima, M., Shirasugi, N., & Niimi, M. (2006) · Transplantation · doi:10.1097/01.tp.0000233870.54297.9a · Cited by 27
Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression
Kassai, F., Schlumberger, C., Kedves, R., Pietraszek, M., Jatzke, C., Lendvai, B., Gyertyán, I., & Danysz, W. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283565248 · Cited by 27
Patkar, A. A., Mannelli, P., Peindl, K., Hill, K. P., Gopalakrishnan, R., & Berrettini, W. H. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0261-7 · Cited by 27
Almeida‐Santos, A. F., Ferreira, R. C. M., Duarte, I. D. G., de Aguiar, D. C., Romero, T. R. L., & Moreira, F. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.053 · Cited by 27
Guenther, U., Wrigge, H., Theuerkauf, N. U., Böettcher, M., Wensing, G., Zinserling, J., Putensen, C., & Hoeft, A. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181eac011 · Cited by 27
Porter, R. H. P., Malcolm, C. S., Allen, N. H., Lamb, H., Revell, D. F., & Sheardown, M. J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00677-3 · Cited by 27
Drugs affecting serotonin receptors
Camilleri, M., & von der Ohe, M. R. (1994) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(94)90006-x · Cited by 27
Self-citationDavis, J. M., Sharpley, A. L., & Cowen, P. J. (1992) · Psychopharmacology · doi:10.1007/bf02245128 · Cited by 27
Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase
Varrault, A., & Bockaert, J. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171076 · Cited by 27
Self-citationGalligan, J. J., & Parkman, H. P. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00970.x · Cited by 27
Pockros, L. A., Pentkowski, N. S., Conway, S. M., Ullman, T. E., Zwick, K. R., & Neisewander, J. L. (2012) · Synapse · doi:10.1002/syn.21592 · Cited by 27
Aubert, Y., Gustison, M. L., Gardner, L. A., Bohl, M. A., Lange, J. R., Allers, K. A., Sommer, B., Datson, N. A., & Abbott, D. H. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02616.x · Cited by 27
Bigford, G. E., Chaudhry, N. S., Keane, R. W., & Holohean, A. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277806 · Cited by 27
Birkeland, J. A. K., Swift, F., Tovsrud, N., Enger, U. H., Lunde, P., Qvigstad, E., Levy, F. O., Sejersted, O. M., & Sjaastad, I. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01375.2006 · Cited by 27
Self-citationGupta, S. K., & Villalón, C. M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.005 · Cited by 27
Self-citationLarkman, P. M., & Kelly, J. S. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.067br.x · Cited by 27
Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels
Zhang, Y., Smith, E. M., Baye, T. M., Eckert, J. V., Abraham, L. J., Moses, E. K., Kissebah, A. H., Martin, L. J., & Olivier, M. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00038.2010 · Cited by 27
Hafdi‐Nejjari, Z., Couette, S., Comoy, E., Prié, D., Amiel, C., & Friedlander, G. (1996) · Biochemical Journal · doi:10.1042/bj3200615 · Cited by 27
Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells.
Li, T., Weng, S., Leng, X.-S., Peng, J., Wei, Y., Mou, D.-C., & Wang, W. (2006) · PubMed · Cited by 26
Birnstiel, S., & Beck, S. G. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09576-x · Cited by 26
(R) and (S) RS 56532: Mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity
Eglen, R. M., Bonhaus, D. W., Clark, R. D., Johnson, L. G., Lee, C. H., Leung, E., Smith, W. L., Wong, E. H. F., & Whiting, R. L. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90083-3 · Cited by 26
Cumming-Hood, P. A., Strahlendorf, H. K., & Strahlendorf, J. C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90485-z · Cited by 26
GAGGI, R., Dall’Olio, R., & Roncada, P. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00240-6 · Cited by 26
Scarr, E., Pavey, G., Copolov, D., & Dean, B. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.007 · Cited by 26
Asaoka, N., Nagayasu, K., Nishitani, N., Yamashiro, M., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.032 · Cited by 26
Ulens, C., Spurný, R., Thompson, A. J., et al. (2014) · Structure · doi:10.1016/j.str.2014.07.013 · Cited by 26
Alberts, G. L., Pregenzer, J. F., Im, W. B., Zaworski, P. G., & Gill, G. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00653-6 · Cited by 26
The 5-hydroxytryptamine 4 Receptor Agonist-induced Actions and Enteric Neurogenesis in the Gut
Takaki, M., Goto, K., & Kawahara, I. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2014.20.1.17 · Cited by 26
Bhattacharya, A., Sankar, S., & Panicker, M. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06493.x · Cited by 26
Gilet, M., Eutamène, H., Han, H. S., Kim, H., & Bueno, L. P. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12458 · Cited by 26
Intracellular 5-HT2C-receptor dephosphorylation: a new target for treating drug addiction
Müller, C. P., & Carey, R. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.003 · Cited by 26
Schmauss, C., Zimnisky, R. M., Mehta, M., & Shapiro, L. P. (2010) · RNA · doi:10.1261/rna.2188110 · Cited by 26
Fugelli, A., Moret, C., & Fillion, G. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709039154 · Cited by 26
The 5-HT3AB Receptor Shows an A3B2 Stoichiometry at the Plasma Membrane
Miles, T. F., Dougherty, D. A., & Lester, H. A. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.07.015 · Cited by 26
Parker, C. A., Rabiner, E. A., Gunn, R. N., Searle, G. E., Martarello, L., Comley, R. A., Davy, M., Wilson, A. A., Houle, S., Mizrahi, R., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.162743 · Cited by 26
Pathways and Barriers for Ion Translocation through the 5-HT3A Receptor Channel
Maio, D. D., Chandramouli, B., & Brancato, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140258 · Cited by 26
Role of SAP97 in the Regulation of 5-HT2AR Endocytosis and Signaling
Dunn, H. A., Walther, C., Yuan, G. Y., Caetano, F. A., Godin, C. M., & Ferguson, S. S. G. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093476 · Cited by 26
Allosteric Inhibition of Serotonin 5-HT7 Receptors by Zinc Ions
Satała, G., Duszyńska, B., Lenda, T., Nowak, G., & Bojarski, A. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0536-0 · Cited by 26
The Behavioral Genetics of Serotonin: Relevance to Anxiety and Depression
O’Leary, O. F., & Cryan, J. F. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70109-0 · Cited by 25
Functional 5-HT receptors in human occipital artery
Verheggen, R., Meier, A. A., Werner, I., et al. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0878-9 · Cited by 25
Serotonin 5-HT2C receptor homodimerization is not regulated by agonist or inverse agonist treatment
Herrick‐Davis, K., Grinde, E., & Weaver, B. A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.030 · Cited by 25
Self-citationBrenchat, A., Rocasalbas, M., Zamanillo, D., Hamon, M., Vela, J. M., & Romero, L. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/312041 · Cited by 25
Association of a 5-HT5A receptor polymorphism, Pro15Ser, to schizophrenia
Iwata, N., Ozaki, N., Inada, T., & Goldman, D. A. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000829 · Cited by 25
Jiménez‐Ferrer, E., Herrera-Ruiz, M. L., Ramírez-García, R., Herrera-Arellano, A., & Tortoriello, J. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.029 · Cited by 25
[ 3 H]‐Mesulergine labels 5‐HT 7 sites in rat brain and guinea‐pig ileum but not rat jejunum
Hemedah, M., Coupar, I. M., & Mitchelson, F. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702293 · Cited by 25
Liu, S., Lane, S. D., Schmitz, J. M., Green, C. E., Cunningham, K. A., & Moeller, F. G. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.10.003 · Cited by 25
Self-citationBinding of tryptamine analogs at h5-HT1E receptors: a structure–affinity investigation
Dukat, M., Smith, C., Herrick‐Davis, K., Teitler, M., & Glennon, R. A. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.026 · Cited by 25
Self-citationRousselle, J.-C., Plantefol, M., Fillion, M., Massot, O., Pauwels, P. J., & Fillion, G. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005254 · Cited by 25
Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement
Valentini, V., Piras, G., Luca, M. A. D., Perra, V., Bordi, F., Borsini, F., Frau, R., & Chiara, G. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.025 · Cited by 25
Distribution of Serotonin 4(a) Receptors in the juvenile Rat Brain and Spinal Cord
Suwa, B., Bock, N., Preuße, S., Rothenberger, A., & Manzke, T. (2014) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2013.12.004 · Cited by 25
Thomas, E. A., Matli, J. R., Hu, J. L., Carson, M. J., & Sutcliffe, J. G. (2000) · Journal of Neuroscience Research · Cited by 25
Pharmacological Evidence for 5-HT6 Receptor Modulation of 5-HT Neuron Firing in Vivo
Brouard, J. T., Schweimer, J. V., Houlton, R., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00061 · Cited by 25
Molecular biology of 5-HT receptors
Hannon, J. P., & Hoyer, D. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8561-3_6 · Cited by 25
Self-citationDevroye, C., Cathala, A., Marco, B. D., Caraci, F., Drago, F., Piazza, P. V., & Spampinato, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.06.012 · Cited by 24
Characterization of 5-HT3 Receptor Mutations Identified in Schizophrenic Patients
Thompson, A. J., Sullivan, N. L., & Lummis, S. C. R. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:3:273 · Cited by 24
Self-citationCanal, C. E., Córdova, T., Villa, N., Fang, L.-J., & Booth, R. G. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.006 · Cited by 24
Orbán, G., Pierucci, M., Benigno, A., et al. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3594-1 · Cited by 24
Stacher, G., Bergmann, H., Schneider, C., Mittelbach, G., Gaupmann, G., Steinringer, H., Abatzi, T.-A., & Stacher-Janotta, G. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03741.x · Cited by 24
Partial Agonism of 5-HT3Receptors: A Novel Approach to the Symptomatic Treatment of IBS-D
Moore, N. A., Sargent, B. J., Manning, D. D., & Guzzo, P. R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300166c · Cited by 24
Effects of serotonin (5-HT)6 receptor ligands on responding for cocaine reward and seeking in rats
Fijał, K., Pachuta, A., McCreary, A. C., Wydra, K., Nowak, E., Papp, M., Bieńkowski, P., Kotlinska, J. H., & Filip, M. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70362-5 · Cited by 24
Self-citationMnie‐Filali, O., Amraei, M. G., Benmbarek, S., Archer-Lahlou, É., Peñas-Cazorla, R., Vilaró, M. T., Boye, S. M., & Piñeyro, G. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.004 · Cited by 24
Sorting nexin‐14, a gene expressed in motoneurons trapped by an in vitro preselection method
Carroll, P., Renoncourt, Y., Gayet, O., de Bovis, B., & Alonso, S. (2001) · Developmental Dynamics · doi:10.1002/dvdy.1163 · Cited by 24
Lin, J. C., Chou, C., Gao, S., Wu, S., Khoo, K., & Lin, C. (2013) · ChemBioChem · doi:10.1002/cbic.201300050 · Cited by 24
Chenu, F., Shim, S., Mansari, M. E., & Blier, P. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113510071 · Cited by 24
Sumiyoshi, T., Higuchi, Y., Matsui, M., Arai, H., Takamiya, C., Meltzer, H. Y., & Kurachi, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.02.017 · Cited by 24
5‐ht5B Receptor mRNA in the raphe nuclei: Coexpression with serotonin transporter
Serrats, J., Raurich, A., Vilaró, M. T., Mengod, G., & Cortés, R. (2003) · Synapse · doi:10.1002/syn.10287 · Cited by 24
Klein, M. T., Dukat, M., Glennon, R. A., & Teitler, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179606 · Cited by 24
Self-citationLuminal 5‐ HT stimulates colonic bicarbonate secretion in rats
Kaji, I., Akiba, Y., Said, H., Narimatsu, K., & Kaunitz, J. D. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13216 · Cited by 24
Zhang, Z., Falaleeva, M., Agranat-Tamir, L., Pagès, A., Eyras, E., Sperling, J. M., Sperling, R., & Stamm, S. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3458-8 · Cited by 24
The 5‐HT3B subunit affects high‐potency inhibition of 5‐HT3receptors by morphine
Baptista‐Hon, D. T., Deeb, T. Z., Othman, N. A., Sharp, D., & Hales, T. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01582.x · Cited by 23
Cloning and pharmacological characterisation of the guinea pig 5-ht5A receptor
Thomas, D. R., Larminie, C. G. C., Lyons, H. R., Fosberry, A. P., Hill, M., & Hayes, P. D. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.027 · Cited by 23
WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics
Grauer, S. M., Graf, R., Navarra, R. L., Sung, A., Logue, S. F., Stack, G., Huselton, C. A., Liu, Z., Comery, T. A., Marquis, K. L., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1433-z · Cited by 23
Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia
Mujakovic, S., Linde, J. J. M. T., de Wit, N. J., van Marrewijk, C. J., Fransen, G. A. J., Onland‐Moret, N. C., Laheij, R. J. F., Muris, J. W. M., Grobbee, D. E., Samsom, M., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-140 · Cited by 23
Polymorphisms of the HTR3B gene are associated with post-surgery emesis in a Chinese Han population
Ma, X., Chen, Q., Wu, S., Hu, Y., & Fang, X. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12033 · Cited by 23
Monti, J. M., Leopoldo, M., & Jantos, H. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.030 · Cited by 23
Self-citationWestrich, L., Sprouse, J. S., & Sánchez, C. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.12.009 · Cited by 23
Stein, D. J., Miczek, K. A., Lucion, A. B., & de Almeida, R. M. M. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3164-z · Cited by 23
Claeysen, S., Faye, P., Sebben, M., Barrère‐Lemaire, S., Bockaert, J., Dumuis, A., & Taviaux, S. A. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134646 · Cited by 23
Self-citationInvolvement of 5‐ HT 3and 5‐ HT 4receptors in colonic motor patterns in rats
Yu, Y., Chen, J. ‐., Li, H.-Y., Yang, Z., Du, X., Hong, L., Liao, H., Jiang, L., Shi, J., Zhao, L., et al. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12550 · Cited by 23
Beer, M. S., Stanton, J. A., Hawkins, L. M., et al. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90243-b · Cited by 23
Antiangiogenic Effect of a Selective 5-HT4 Receptor Agonist
Nishikawa, T., Tsuno, N. H., Shuno, Y., Sasaki, K., Hongo, K., Okaji, Y., Sunami, E., Kitayama, J., Takahashi, K., & Nagawa, H. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.11.004 · Cited by 23
5-HT Receptor Signal Transduction Pathways
Turner, J. H., Gelasco, A. K., Ayiku, H., Coaxum, S. D., Arthur, J. M., & Garnovskaya, M. N. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-080-5_5 · Cited by 23
KLEENE, R. B., Chaudhary, H., Karl, N., Katić, J., Kotarska, A., Guitart, K., Loers, G., & Schachner, M. (2015) · Journal of Cell Science · doi:10.1242/jcs.176941 · Cited by 23
Hallucinogens and serotonergic mechanisms.
Glennon, R. A., Teitler, M., & Sanders‐Bush, E. (1992) · PubMed · Cited by 23
Self-citationXu, R., Hong, J. S., Morse, C. L., & Pike, V. W. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100668r · Cited by 22
Garcia‐García, Á. L., Meng, Q., Richardson-Jones, J. W., Dranovsky, A., & Leonardo, E. D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.076 · Cited by 22
Serotonin-Mediated Tuning of Human Helper T Cell Responsiveness to the Chemokine CXCL12
Magrini, E. I., Szabó, I., Doni, A., Cibella, J., & Viola, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022482 · Cited by 22
Dando, S. B., Skinner, M. R., Jordan, D., & Ramage, A. G. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702085 · Cited by 22
Murotani, T., Ishizuka, T., Isogawa, Y., Karashima, M., & Yamatodani, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.003 · Cited by 22
Lopreato, G. F., Banerjee, P., & Mihic, S. J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00332-2 · Cited by 22
Rings of Charge within the Extracellular Vestibule Influence Ion Permeation of the 5-HT3A Receptor
Livesey, M. R., Cooper, M. A., Lambert, J. J., & Peters, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219618 · Cited by 22
Bhasin, N., LaMantia, A., & Lauder, J. M. (2004) · Anatomy and Embryology · doi:10.1007/s00429-004-0380-7 · Cited by 22
A novel regulator of angiogenesis in endothelial cells: 5-hydroxytriptamine 4 receptor
Profirovic, J., Strekalova, E., Urao, N., Krbanjevic, A., Andreeva, A. V., Varadarajan, S., Fukai, T., Hen, R., Ushio‐Fukai, M., & Voyno-Yasenetskaya, T. (2012) · Angiogenesis · doi:10.1007/s10456-012-9296-7 · Cited by 22
Bassil, A., Taylor, C., Bolton, V. J., Gray, K., Brown, J. D., Cutler, L., Summerfield, S. G., Bruton, G., Winchester, W., Lee, K., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00155.x · Cited by 22
Self-citationFamily-based association studies between 5-HT5A receptor gene and schizophrenia
Dubertret, C., Hanoun, N., Adès, J., Hamon, M., & Gorwood, P. A. P. M. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.01.002 · Cited by 22
Ferreira, H. S., Oliveira, E., Faustino, T. N., Silva, E. D. C. E., & Fregoneze, J. B. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.054 · Cited by 22
Ren, J., Zhou, X., & Galligan, J. J. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00078.2008 · Cited by 22
Striatal 5-HT6 Receptors Regulate Cocaine Reinforcement in a Pathway-Selective Manner
Brodsky, M., Gibson, A. W., Smirnov, D. S., Nair, S. G., & Neumaier, J. F. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.45 · Cited by 22
Self-citationEffect of 5‐hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation
Amano, T., Ariga, H., Kurematsu, A., Yamato, S., MORIOKA, S., Masaka, A., Kanazawa, M., & Fukudo, S. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12623 · Cited by 21
Genetic variation in HTR4 and lung function: GWAS follow‐up in mouse
House, J. S., Li, H., DeGraff, L. M., Flake, G. P., Zeldin, D. C., & London, S. J. (2014) · The FASEB Journal · doi:10.1096/fj.14-253898 · Cited by 21
Heterogeneous Rate of Protein Evolution in Serotonin Genes
Andrés, A. M., de Hemptinne, C., & Bertranpetit, J. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm202 · Cited by 21
Serotonergic signalling in the stomach and duodenum of patients with gastroparesis
van Lelyveld, N., ter Linde, J., Schipper, M., & Samsom, M. (2008) · Neurogastroenterology and Motility · doi:10.1111/j.1365-2982.2007.01068.x · Cited by 21
Assignment of a Human Homolog of the Mouse Htr3 Receptor Gene to Chromosome 11q23.1-q23.2
Weiß, B., Mertz, A., Schröck, E., Koenen, M., & Rappold, G. (1995) · Genomics · doi:10.1006/geno.1995.1254 · Cited by 21
Monoamine modulation of tonic GABAA inhibition
Crunelli, V., & Giovanni, G. D. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0059 · Cited by 21
DiMagno, L., Dascal, N., Davidson, N., Lester, H. A., & Schreibmayer, W. (1996) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf02207270 · Cited by 21
RhoBTB3 interacts with the 5-HT7a receptor and inhibits its proteasomal degradation
Matthys, A., Craenenbroeck, K. V., Lintermans, B., Haegeman, G., & Vanhoenacker, P. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.027 · Cited by 21
The 5-HT2B Receptor Gene Maps to 2q36.3–2q37.1
Coniat, M. L., Choi, D., Maroteaux, L., Launay, J., & Berger, R. (1996) · Genomics · doi:10.1006/geno.1996.0101 · Cited by 21
Self-citationReid, T.-E. R., Kumar, K., & Wang, X. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990039 · Cited by 21
Prinssen, E. P. M., Koek, W., Colpaert, F. C., & Kleven, M. S. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200006000-00013 · Cited by 21
McKinnell, R. M., Armstrong, S. R., Beattie, D. T., Fatheree, P. R., Long, D. D., Marquess, D. G., Shaw, J., & Vickery, R. G. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.018 · Cited by 20
Futuro-Neto, H. A., Pires, J. G. P., Gilbey, M. P., & Ramage, A. G. (1993) · Brain Research · doi:10.1016/0006-8993(93)91345-s · Cited by 20
Zgombick, J. M., & Branchek, T. A. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005285 · Cited by 20
Levy, F. O., Holtgreve-Grez, H., Taskén, K., Solberg, R., Ried, T., & Gudermann, T. W. (1994) · Genomics · doi:10.1006/geno.1994.1439 · Cited by 20
Self-citationDeconstructing 5-HT6 receptor effects on striatal circuit function
Eskenazi, D., Brodsky, M., & Neumaier, J. F. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.046 · Cited by 20
Self-citation5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail
Barclay, Z., Dickson, L., Robertson, D. N., Johnson, M. S., Holland, P. J., Rosie, R., Sun, L., Fleetwood‐Walker, S., Lutz, E. M., & Mitchell, R. (2011) · Biochemical Journal · doi:10.1042/bj20101844 · Cited by 20
Vogrig, A., Dorr, L., Bouzidi, N., Boucherle, B., Wattiez, A., Cassier, E., Vallon, G., Ripoche, I., Abrunhosa, I., Marin, P., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400308u · Cited by 20
Self-citationVillalón, C. M., Sánchez‐López, A., Centurión, D., & Saxena, P. R. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000333 · Cited by 20
Self-citationAllosteric Modulation of G Protein-Coupled Receptors: An Emerging Approach of Drug Discovery.
Wild, C., Cunningham, K. A., & Zhou, J. (2014) · PubMed · Cited by 20
Self-citationvan Gaalen, M. M., Schetters, D., Schoffelmeer, A. N. M., & Vries, T. J. D. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000428 · Cited by 20
Palonosetron–5-HT3 Receptor Interactions As Shown by a Binding Protein Cocrystal Structure
Price, K. L., Lillestøl, R., Ulens, C., & Lummis, S. C. R. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00132 · Cited by 20
Self-citationmRNA and microRNA expression patterns in adrenocortical cancer.
Zsippai, A., Szabó, D. R., Szabó, P. M., Tömböl, Z., Bendes, M. R., Nagy, Z., Rácz, K., & Igaz, P. (2011) · PubMed · Cited by 19
PTEN-5-HT2C coupling: a new target for treating drug addiction
Maillet, J., ZHANG, Y., LI, X., & Zhang, X. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00920-5 · Cited by 19
Meta‐chlorophenylpiperazine enhances leptin sensitivity in diet‐induced obese mice
Yan, C., Yang, Y., Saito, K., Xu, P., Wang, C., Hinton, A. O., Jr., Yan, X., Wu, Q., Tong, Q., Elmquist, J. K., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13141 · Cited by 19
Serotonin 2B Receptor (5-HT2B R) Signals through Prostacyclin and PPAR-ß/δ in Osteoblasts
Chabbi-Achengli, Y., Launay, J., Maroteaux, L., de Vernejoul, M. C., & Collet, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075783 · Cited by 19
Self-citationShelton, J. E., Yun, S., Olson, S. L., Turek, F. W., Bonaventure, P., Dvorak, C. A., Lovenberg, T. W., & Dugovic, C. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00453 · Cited by 19
Mutational analysis of the serotonin receptor 5HT2c in severe early-onset human obesity
Gibson, W. T., Ebersole, B. J., Bhattacharyya, S., Clayton, P., Farooqi, I. S., Sealfon, S. C., & O’Rahilly, S. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-025 · Cited by 19
Kawahara, I., Kuniyasu, H., Matsuyoshi, H., Goto, K., Obata, K., Misawa, H., Fujii, H., & Takaki, M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00284.2011 · Cited by 19
Jin, H. K., Bae, J., Furuya, S., & Carter, J. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00625.x · Cited by 19
Schneider, B., Pietri, M., Mouillet‐Richard, S., Ermonval, M., Mutel, V., Launay, J., & Kellermann, O. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.061 · Cited by 19
Damjanoska, K. J., Muma, N. A., Zhang, Y., D’Souza, D. N., García, F., Carrasco, G. A., Kindel, G. H., Haskins, K. A., Shankaran, M., Petersen, B. R., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043489 · Cited by 19
Serotonin receptor 5-HT5A in rat hippocampus decrease by leptin treatment
García‐Alcocer, G., Rodríguez, A., Moreno‐Layseca, P., Berumen, L. C., Escobar-Cabrera, J. E., & Miledi, R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.045 · Cited by 19
Lanfranco, M. F., Seitz, P. K., Morabito, M. V., Emeson, R. B., Sanders‐Bush, E., & Cunningham, K. A. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.01.027 · Cited by 19
Self-citationGasiorek, A., Trattnig, S. M., Ahring, P. K., Kristiansen, U., Frølund, B., Frederiksen, K., & Jensen, A. A. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.04.004 · Cited by 19
Nutt, D. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675754 · Cited by 19
Altered ADAR 2 equilibrium and 5HT2CR editing in the prefrontal cortex of ADAR 2 transgenic mice
Singh, M., Singh, M. M., Na, E., Agassandian, K., Zimmerman, M. B., & Johnson, A. K. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00701.x · Cited by 18
Werry, T. D., Stewart, G. D., Crouch, M. F., Watts, A. O., Sexton, P. M., & Christopoulos, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.024 · Cited by 18
Phosphodiesterase 4 interacts with the 5-HT4(b) receptor to regulate cAMP signaling
Weninger, S., Craenenbroeck, K. V., Cameron, R. T., Vandeput, F., Movsesian, M. A., Baillie, G. S., & Lefebvre, R. A. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.027 · Cited by 18
Monti, J. M., Jantos, H., & Schechter, L. E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.024 · Cited by 18
Regulation of serotonin 5-HT2C receptors by chronic ligand exposure
Devlin, M. G., Smith, N. J., Ryan, O. M., Guida, E., Sexton, P. M., & Christopoulos, A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.102 · Cited by 18
Odagaki, Y., & Toyoshima, R. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj05010x · Cited by 18
The serotonin-2 receptor modulator, (-)-trans-PAT, decreases voluntary ethanol consumption in rats
Kasper, J. M., Tikamdas, R., Kim, M. S., MacFadyen, K. A., Aramini, R., Ladd, J., Bisceglia, S., Booth, R. G., & Peris, J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.008 · Cited by 18
Smith, M. I., Banner, S. E., & Sanger, G. J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00513-3 · Cited by 18
Self-citationWattiez, A., Pichon, X., Dupuis, A., Hernández, A., Privat, A.-M., Aissouni, Y., Chalus, M., Pélissier, T., Eschalier, A., Marin, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074661 · Cited by 18
Self-citationPimavanserin as treatment for Parkinson's disease psychosis
Fox, S. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62157-1 · Cited by 18
Horiuchi, J., Wakabayashi, S., & Dampney, R. A. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000169970.68151.17 · Cited by 18
5‐ C hloroindole: a potent allosteric modulator of the 5‐ HT 3 receptor
Newman, A. S., Batis, N., Grafton, G., Caputo, F., Brady, C., Lambert, J. J., Peters, J. A., Gordon, J. C., Brain, K. L., Powell, A. D., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12213 · Cited by 17
Self-citationCurrent radiosynthesis strategies for 5‐HT2A receptor PET tracers
Herth, M. M., & Knudsen, G. M. (2015) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3288 · Cited by 17
Gobbi, M., Parotti, L., & Mennini, T. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08743-7 · Cited by 17
Switching-on of serotonergic calcium signaling in activated hepatic stellate cells
Park, K. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i2.164 · Cited by 17
Dupuis, D. S., Pauwels, P. J., Radu, D., & Hall, H. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00600.x · Cited by 17
Weninger, S., Maeyer, J. H. D., & Lefebvre, R. A. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0746-y · Cited by 17
Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3k
Martelaere, K. D., Lintermans, B., Haegeman, G., et al. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.06.012 · Cited by 17
Kim, J., Park, B., Cheong, H. S., Bae, J. S., Kim, L. H., Kim, J. W., Lee, B. C., Seo, C. H., Kang, T., Park, S. Y., et al. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12482 · Cited by 17
Tavares, A., Caillé, F., Barret, O., Papin, C., Lee, H. S., Morley, T. J., Fowles, K., Holden, D., Seibyl, J. P., Alagille, D., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.132712 · Cited by 17
Electrophysiology of Serotonin Receptors
Marek, G. J. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70077-1 · Cited by 17
Mohammadi, M.-R., Hafezi, P., Galeiha, A., Hajiaghaee, R., & Akhondzadeh, S. (2012) · PubMed · Cited by 17
5-Hydroxytryptamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Andrade, R., Barnes, N. M., Baxter, G. S., Bockaert, J., Branchek, T. A., Butler, A. S., Cohen, M. L., Dumuis, A., Eglen, R. M., Göthert, M., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f1/2019.4 · Cited by 17
Self-citationThe serotonin receptor 5-HT7R regulates the morphology and migratory properties of dendritic cells
Holst, K., Guseva, D., Schindler, S., Sixt, M., Braun, A., Chopra, H., Pabst, O., & Ponimaskin, E. G. (2015) · RWTH Publications (RWTH Aachen) · Cited by 17
Cellular and Subcellular Localization of Serotonin Receptors in the Central Nervous System
Descarries, L., Cornea-Hébert, V., & Riad, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-080-5_9 · Cited by 16
Møller, T. C., Wirth, V. F., Roberts, N. I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063352 · Cited by 16
5-HT1A receptor-mediated G protein activation assessed by [35S]GTPγS binding in rat cerebral cortex
Odagaki, Y., & Toyoshima, R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.07.018 · Cited by 16
MacFarlane, P. M., Vinit, S., & Mitchell, G. S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.014 · Cited by 16
Maeyer, J. H. D., Aerssens, J., Verhasselt, P., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00038.2008 · Cited by 16
Identification and functional significance of N-glycosylation of the 5-ht5A receptor
Dutton, A. C., Massoura, A. N., Dover, T. J., Andrews, N. A., & Barnes, N. M. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.07.020 · Cited by 16
Self-citationGoodfellow, N. M., Sargin, D., Ansorge, M. S., Gingrich, J. A., & Lambe, E. K. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3762-13.2014 · Cited by 16
Self-citationPopovic, M., Stanojević, Ž., Tasić, J., Isaković, A., Paunović, V., Petricevic, S. M., Martinović, T., Ćirić, D., Kravic‐Stevovic, T., Šoškić, V., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13198 · Cited by 16
Bowersox, S. S., Lightning, L. K., Rao, S. S. C., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037564 · Cited by 16
Smith, T. K., Dickson, E. J., Heredia, D. J., Hennig, G. W., & Bayguinov, P. O. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.057 · Cited by 16
Mitral bioprosthesis hypertrophic scaring and native aortic valve fibrosis during benfluorex therapy
Ayme‐Dietrich, E., Lawson, R., Gasser, B., Dallemand, R., Bischoff, N., & Monassier, L. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01027.x · Cited by 15
Tegaserod for Constipation‐Predominant Irritable Bowel Syndrome
Kale-Pradhan, P. B., & Wilhelm, S. M. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.2.267 · Cited by 15
Sawant‐Basak, A., Coffman, K. J., Walker, G. S., Ryder, T. F., Tseng, E., Miller, E. L., Lee, C., Vanase-Frawley, M. A., Wong, J. W., Brodney, M. A., et al. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23542 · Cited by 15
Cloning and Functional Promoter Mapping of the Rat Serotonin-2 Receptor Gene
Garlow, S. J., Chin, A. C., Marinovich, A. M., Heller, M. R., & Ciaranello, R. D. (1994) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1994.1034 · Cited by 15
Distribution of 5‐HT2C and 5‐ht5a Receptor mRNA in Human Brain
Pasqualetti, M., Ori, M., Marazziti, D., Castagna, M., & Nardi, I. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10202.x · Cited by 15
Sertindole in the Management of Schizophrenia
Juruena, M. F., Sena, E. P. C. D., & de Oliveira, I. R. (2011) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s5729 · Cited by 15
Esparza, S. L., Berumen, L. C., Padilla, K., Miledi, R., & García‐Alcocer, G. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.02.010 · Cited by 15
Inhibition of human 5-HT3A and 5-HT3AB receptors by etomidate, propofol and pentobarbital
Rüsch, D., Braun, H., Wulf, H., Schuster, A., & Raines, D. E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.009 · Cited by 15
Bioinformatic analyses to select phenotype affecting polymorphisms in HTR2C gene
Piva, F., Giulietti, M., Baldelli, L., Nardi, B., Bellantuono, C., Armeni, T., Saccucci, F., & Principato, G. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1214 · Cited by 15
Du, Y., Wilcox, B. D., & Jeffrey, J. J. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08602-x · Cited by 15
Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig.
Weydert, A., Cloëz-Tayarani, I., Mp, F., Simon‐Chazottes, D., Jl, G., & Fillion, G. (1992) · PubMed · Cited by 15
Massoura, A. N., Dover, T. J., Newman, A. S., & Barnes, N. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07129.x · Cited by 14
Self-citationSpecies Differences in the Formation of Vabicaserin Carbamoyl Glucuronide
Tong, Z., Chandrasekaran, A., DeMaio, W., Jordan, R. A., Li, H., Moore, R., Poola, N., Burghart, P. H., Hultin, T. A., & Scatina, J. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028639 · Cited by 14
Association between the HTR2B gene and the personality trait of fun seeking
Zhu, B., Chen, C., Moyzis, R. K., Dong, Q., Chen, C., He, Q., Li, J., Lei, X., & Lin, C. (2012) · Personality and Individual Differences · doi:10.1016/j.paid.2012.07.026 · Cited by 14
Walstab, J., Steinhagen, F., Brüss, M., Göthert, M., & Bönisch, H. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70397-8 · Cited by 14
Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series
Okita, K., Shiina, A., Nakazato, M., & Iyo, M. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-7 · Cited by 14
Vianna, D. M. L., & Carrive, P. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00232.2009 · Cited by 14
Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists
Rouquet, G., Moore, D. E., Spain, M. P., Allwood, D. M., Battilocchio, C., Blakemore, D. C., Fish, P. V., Jenkinson, S. G., Jessiman, A. S., Ley, S. V., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500507v · Cited by 14
The Role of 5-HT2C Receptor in Epilepsy
Jakus, R., & Bagdy, G. (2010) · The Receptors · doi:10.1007/978-1-60761-941-3_22 · Cited by 14
Sharp, T. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70081-3 · Cited by 13
Self-citationNeurochemical Imaging and Depressive Behaviours
Meyer, J. H. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_219 · Cited by 13
Spedding, M., Newman‐Tancredi, A., Millan, M. J., Dacquet, C., Michel, A. G., Jacoby, E., VICKERY, B. H., & Tallentire, D. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00065-3 · Cited by 13
Self-citationDo polymorphisms in the human 5-HT3 genes contribute to pathological phenotypes?
Krzywkowski, K. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340872 · Cited by 13
Borsini, F., Bordi, F., Poggi, A., & Matteo, V. D. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573804 · Cited by 13
Corradetti, R., Mlinar, B., Falsini, C., Pugliese, A. M., Cilia, A., Destefani, C., & Testa, R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087809 · Cited by 13
Grottick, A. J., Whelan, K. T., Sanabria, E. K., Behan, D. P., Morgan, M. E., & Sage, C. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3829-2 · Cited by 13
Salom, D., Wang, B., Dong, Z., Sun, W., Padayatti, P. S., Jordan, S. R., Salon, J. A., & Palczewski, K. (2011) · Biochemistry · doi:10.1021/bi201707v · Cited by 13
Cellular Effects of Serotonin in the CNS
Andrade, R., & Beck, S. G. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70080-1 · Cited by 12
Cited by
Tryptophan metabolism and gut-brain homeostasis
Roth, W., Zadeh, K., Vekariya, R., Ge, Y., & Mohamadzadeh, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062973 · Cited by 519
Structural insights into the lipid and ligand regulation of serotonin receptors
Xu, P., Huang, S., Zhang, H., Mao, C., Zhou, X. E., Cheng, X., Simon, I. A., Shen, D.-D., Yen, H.-Y., Robinson, C. V., et al. (2021) · Nature · doi:10.1038/s41586-021-03376-8 · Cited by 270
The neurobiology of social play behaviour: Past, present and future
Achterberg, E. J. M., & Vanderschuren, L. J. M. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105319 · Cited by 56
Metadata
- Authors
- Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., Di Giovanni, G., Goodfellow, N. M., Halberstadt, A. L., Hartley, R. M., Hassaine, G., Herrick-Davis, K., Hovius, R., Lacivita, E., Lambe, E. K., Leopoldo, M., Levy, F. O., Lummis, S. C. R., Marin, P., Maroteaux, L., McCreary, A. C., Nelson, D. L., Neumaier, J. F., Newman-Tancredi, A., Nury, H., Roberts, A., Roth, B. L., Roumier, A., Sanger, G. J., Teitler, M., Sharp, T., Villalón, C. M., Vogel, H., Watts, S. W., & Hoyer, D.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 73
- Issue
- 1
- Pages
- 310-520
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W3116452987
- Cited by
- 263
- References
- 2,264
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.